Craneware 

$24.20
30
+$0.00+0% Wednesday 13:30

統計

當日最高
24.2
當日最低
24.2
52週高點
34
52週低點
24.2
成交量
-
平均成交量
-
市值
860.12M
本益比
41.75
股息殖利率
1.83%
股息
0.44

即將到來

股息

1.83%股息殖利率
Apr 26
$0.20
Dec 25
$0.24
Apr 25
$0.18
Dec 24
$0.20
Apr 24
$0.17
10年成長
6.84%
5年成長
4.05%
3年成長
5.51%
1年成長
4.69%

財報

22Sep預期
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
下一步
33.49
36.64
39.8
42.95
預期EPS
不適用
實際EPS
不適用

財務

9.56%利潤率
有盈利
2019
2020
2021
2022
2023
2024
411.31M營收
39.33M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CRWRF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Craneware plc, alongside its various subsidiaries, is dedicated to developing, licensing, and providing ongoing support for specialized software solutions within the United States healthcare industry. The company's comprehensive suite of products addresses a wide range of operational and financial needs. For revenue cycle and financial management, Craneware offers Trisus pricing transparency software, designed to clarify pricing information, along with Trisus Pricing Analyzer to automate and simplify price modeling. Its Trisus Chargemaster provides automated management of chargemaster data, while InSight Audit assists government and commercial payors with audit processes. Additionally, InSight Denials facilitates the analysis, tracking, and reporting of claims denial data, and Trisus Claims Informatics offers retrospective analytical insights to identify charge capture risks. In the realm of clinical operations and supply chain, solutions include InSight Medical Necessity, which helps U.S. payors determine medical necessity; Trisus Supply, aimed at enhancing reimbursement for medical supplies; and Trisus Healthcare Intelligence, delivering patient-level insights into resource consumption. The portfolio also extends to Trisus Medication Analytic and Trisus Supplies Assistant solutions. Craneware also features a specialized line of pharmacy and drug tracking software. This includes Sentinel for drug tracking, Sentrex (a SaaS platform enabling covered entities to expand medication access), Sentrex 330, a Referral Verification System, and Sentry Core, which streamlines the complexities of pharmacy procurement, utilization, and compliance. Beyond its software offerings, Craneware provides professional and appeal services. The company was founded in 1999 and is headquartered in Edinburgh, United Kingdom.
Show more...
執行長
Mr. Keith Neilson
員工
747
國家
美國
ISIN
GB00B2425G68

上市

0 Comments

分享你的想法

FAQ

Craneware 今天的股價是多少?
CRWRF 目前價格為 $24.20 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Craneware 股價表現。
Craneware 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Craneware 的股票以代號 CRWRF 進行交易。
Craneware 的市值是多少?
今天 Craneware 的市值為 860.12M
Craneware 下一次財報日期是什麼時候?
Craneware 將於 September 22, 2026 公布下一次財報。
Craneware 上一季度的財報如何?
CRWRF 上一季度的財報為每股 0.58 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
Craneware 去年的營收是多少?
Craneware 去年的營收為 411.31MUSD。
Craneware 去年的淨利是多少?
CRWRF 去年的淨收益為 39.33MUSD。
Craneware 會發放股息嗎?
是的,CRWRF 的股息每 半年一次 發放一次。每股最新股息為 0.2 USD。截至今日,股息殖利率(FWD)% 為 1.83%。
Craneware 有多少名員工?
截至 June 21, 2026,公司共有 747 名員工。
Craneware 位於哪個產業?
Craneware從事於Health & Wellness產業。
Craneware 何時完成拆股?
Craneware 最近沒有進行任何拆股。
Craneware 的總部在哪裡?
Craneware 的總部位於 美國 的 Edinburgh。